The live attenuated chimeric vaccine rWN/DEN4Δ30 is well-tolerated and immunogenic in healthy flavivirus-naïve adult volunteers.
about
Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic ReviewVaccine-mediated immunity against dengue and the potential for long-term protection against diseaseA Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple FormulationsPlant-made vaccines against West Nile virus are potent, safe, and economically feasibleAssurance of neuroattenuation of a live vaccine against West Nile virus: a comprehensive study of neuropathogenesis after infection with chimeric WN/DEN4Δ30 vaccine in comparison to two parental viruses and a surrogate flavivirus reference vaccine.Current trends in West Nile virus vaccine development.Correlation between serum levels of anti-endothelial cell autoantigen and anti-dengue virus nonstructural protein 1 antibodies in dengue patientsA review of the epidemiological and clinical aspects of West Nile virus.Current developments in understanding of West Nile virus central nervous system disease.RNA-based viral vectors.Technologies for the development of West Nile virus vaccines.An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection.Substitution of the premembrane and envelope protein genes of Modoc virus with the homologous sequences of West Nile virus generates a chimeric virus that replicates in vertebrate but not mosquito cellsA Live Attenuated Chimeric West Nile Virus Vaccine, rWN/DEN4Δ30, Is Well Tolerated and Immunogenic in Flavivirus-Naive Older Adult Volunteers.Are we prepared for emerging flaviviruses in Europe? Challenges for vaccination.The Immune Responses of the Animal Hosts of West Nile Virus: A Comparison of Insects, Birds, and Mammals.
P2860
Q26700078-03C5154F-9CD8-4281-ADED-C30935BC031EQ27014663-D1171956-AC1C-4EF6-950F-A311CE19682AQ27321020-E0C5E342-E506-44C4-9B78-8717F78EA4DDQ28082778-FE6E75DB-9BCF-4E62-A0A1-8BBE372BEF9FQ33909344-CF54BC1A-4A5C-4C2D-880C-102A35135488Q34788758-67952F67-FB3E-4B3A-8999-34B2CCE7C5E7Q35590817-99EFDD90-32BB-48B4-87D8-A9F0D171C521Q37708659-6B3D85B6-5634-48A5-B4D7-AF83490F7187Q38203769-B4BD0658-C864-49FC-A078-57C3E973B270Q38266413-E9BD5D47-1BA1-4773-8950-AB8F9DE82E11Q38269151-55E14460-8A41-465E-983F-941CF6D9184EQ38866173-2953FD97-F32E-4009-832E-7867620C8CAFQ38963356-561F3467-95BA-408E-A481-159EC1D66317Q40073429-A9CC2C2F-BB2E-46BC-B61B-3C62B4324848Q43047253-35142577-F8F8-46FD-AC66-CEC3A0229A93Q52880885-E84C9E5D-BCA7-4D45-9D44-7136765C9FD2
P2860
The live attenuated chimeric vaccine rWN/DEN4Δ30 is well-tolerated and immunogenic in healthy flavivirus-naïve adult volunteers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The live attenuated chimeric v ...... ivirus-naïve adult volunteers.
@en
The live attenuated chimeric v ...... ivirus-naïve adult volunteers.
@nl
type
label
The live attenuated chimeric v ...... ivirus-naïve adult volunteers.
@en
The live attenuated chimeric v ...... ivirus-naïve adult volunteers.
@nl
prefLabel
The live attenuated chimeric v ...... ivirus-naïve adult volunteers.
@en
The live attenuated chimeric v ...... ivirus-naïve adult volunteers.
@nl
P2093
P2860
P1433
P1476
The live attenuated chimeric v ...... ivirus-naïve adult volunteers.
@en
P2093
Alexander G Pletnev
Daniel Elwood
Jim Speicher
Kimberli Wanionek
Peter F Wright
Susan Henderson
Wangeci Kagucia
P2860
P304
P356
10.1016/J.VACCINE.2013.07.064
P407
P577
2013-08-19T00:00:00Z